|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 达比加群酯甲磺酸盐>> 市场分析报告 |
达比加群酯甲磺酸盐市场分析报告 |
|
Research Report on China's Dabigatran Etexilate Market, 2021-2025 ... Ingelheim under the trade name of Pradaxa®, were approved for marketing by EMA ... Global Market Report of Dabigatran etexilate mesylate (CAS 872728-81-9) December 2024 THERAPEUTIC CLASS REPORT: WILL NEXT GENERATION ORAL ANTICOAGULANTS REPLACE WARFARIN AS MAINSTAY THERAPY ... ERA OF NEXT GENERATION ORAL ANTICOAGULANTS Pradaxa: With first mover advantage, Will ... to the new generation of oral anticoagulants (Pradaxa, Xarelto, Eliquis and Edoxaban), which ... Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: Perspective for the Future REPORT INCLUDES: An overview of top five opportunities for generic or biosimilar drugs in pharmaceuticals market 2019 Coverage of generics and discussion on their characteristics Information on Hatchmann-Wax act and its effect on market competitiveness ... Anticoagulants: Market Research Report This report analyzes the worldwide markets for Anticoagulants in US$ Million by the following Segments: Oral Anticoagulants, and Injectable Anticoagulants (Unfractionated Heparin, & Low Molecular Weight Heparin). The report provides separate comprehensive ... Global Dibigatran Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 ... market status of stroke (Pradaxa, Pradax), deep vein thrombosis (Pradaxa, Pradax), and ... market share of different by Type (e.g., Pradaxa, Pradax). Industry Analysis: Report analyse ... and value. Market segment by Type Pradaxa Pradax Prazaxa Market segment by ... Global Dibigatran Market Growth 2024-2030 ... historical data, market segmentation by Type (e.g., Pradaxa, Pradax), and regional breakdowns. Market ... of volume and value. Segmentation by type Pradaxa Pradax Prazaxa Segmentation by application stroke ... Global Dibigatran Market Report 2020 ... (5 6 7): 500 USD—— Product Type Segmentation Pradaxa Pradax Prazaxa Industry Segmentation stroke ... Global Dibigatran Market Insights, Forecast to 2029 ... Industries Ltd. (Israel) Segment by Type Pradaxa Pradax Prazaxa Segment by Application stroke ... Global Pharmaceutical & Biotechnology Outlook 2012 Outlook-11’ is an extensive, yet conclusive research work that encompasses a comprehensive, historical and forward looking analysis of ~80 small and large cap US, EU, Japan and ROW companies – formulated with an aim to facilitate strategic and long term ... Anticoagulants Market by Drug Class (NOACs, Heparin & LMWH, Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant and Injectable Anticoagulant), and Application (Atrial Fibrillation & Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025 ... Eliquis Bevyxxa Xarelto Savaysa & lixiana Pradaxa Heparin & LMWH Vitamin K antagonist Others ... Dibigatran Market - Global Outlook and Forecast 2022-2028 ... China is Forecast to Reach $ Million by 2028. Pradaxa Segment to Reach $ Million by 2028, with ... Market Segment Percentages, by Type, 2021 (%) Pradaxa Pradax Prazaxa Global Dibigatran Market ... Physician Views: How do European cardiologists perceive oral anticoagulants versus warfarin? – Is Eliquis, Pradaxa or Xarelto their favoured option? ... over Xarelto and Boehringer Ingelheim's Pradaxa was not a widely held view ... oral anticoagulants? Which product – Eliquis, Pradaxa or Xarelto – is their favoured treatment option ... Global Anticoagulant Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025 ... Market is studied across Betrixaban, Dabigatran (Pradaxa), Edoxaban, Rivaroxaban (Xarelto), and Eliquis ... Anticoagulants Market Size, Trends, Analysis, and Outlook By Drug Category (Novel oral anticoagulants (NOACs), Heparin and Low Molecular Weight Heparin (LMWH), Vitamin k Antagonist, Direct thrombin inhibitors, Others), By Route of Administration (Oral anticoagulants, Injectable anticoagulants), By Application (Atrial Fibrillation/Myocardial Infarction (Heart Attack), Deep Vein Thrombosis (DVT), Pulmonary Embolism, Others), by Region, Country, Segment, and Companies, 2024-2030 ... (NOACs) -Eliquis -Xarelto -Savaysa & Lixiana -Pradaxa Heparin and Low Molecular Weight ... Global Clot Busting Drugs Market Size study & Forecast, by Product (Thrombolytic Drugs, Anti-Platelet Drugs, Anticoagulants, Others) by Indication (Deep Vein Thrombosis, Atrial Fibrillation, Pulmonary Embolism, Others), by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacy, Drug Store, Online Pharmacy, Retail Pharmacy) and Regional Analysis, 2023-2030 ... dabigatran etexilate, the active ingredient in Pradaxa. Pradaxa oral pellets were given FDA ... Direct Oral Anticoagulant (DOAC) Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type ... limits overall growth. Dabigatran: Sold as Pradaxa by Boehringer Ingelheim, dabigatran is a thrombin inhibitor ... patent expirations. Boehringer Ingelheim: Its Pradaxa (dabigatran) remains a key player, though ... Direct-To-Consumer (DTC) Advertising in Pharmaceuticals: Market Research Report This report analyzes the US market for Direct-To-Consumer (DTC) Advertising in Pharmaceuticals in US$ Million by the following media channels - Internet Advertising, Print Media, Television, and Others (include Outdoor and Radio Advertising). Annual ... Cardiovascular Drugs market ... rivulet of new products such as Xarelto, Pradaxa, Eliquis, and Savaysa. Benefits: The ... Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Andexanet Alfa, Idarucizumab, Phytonadione (Vitamin K)), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 ... indicated for patients treated with Pradaxa (dabigatran) during emergency surgery or uncontrolled ... |